As the Society continues to increase its advocacy and media outreach efforts, the need for Society position statements on key issues has increased. Congress, regulators, and the media regularly approach the Society for its opinion on policy matters. Therefore, the Society needs to have strong member-driven statements to take a leadership role in guiding public discourse in these important areas. To that end, with oversight by APOCC, the Society is in the process of developing a compendium of position statements to support its advocacy efforts on key issues.  The primary intended audiences for these statements are lay audiences—policy makers, the general public, and the media. 

Bioequivalence of Sodium Levothyroxine

Steroid Abuse

Biomedical Research Funding

Access to Affordable and Adequate Diabetes Supplies

Monitoring and Reporting Drug Shortages

Bioidentical Hormones 

Pay-for-Performance 

Clinical Trial Registries 

Stem Cell Research

Other Society Statements

The Endocrine Society Statement on ACCORD Trial

Joint Statement on Levothyroxine and Thyroxine (PDF)

Statement to Providers on the Report Published in the New England Journal of Medicine on Avandia

Summary of Medicare Reform Legislation (PDF)

Position Statements Under Review

Note: When documents are available for review a link will display below. You must enter your member ID and password to comment on documents.